FI102372B1 - Menetelmä karbamyylijohdannaisen kiteisen muodon valmistamiseksi - Google Patents

Menetelmä karbamyylijohdannaisen kiteisen muodon valmistamiseksi

Info

Publication number
FI102372B1
FI102372B1 FI923869A FI923869A FI102372B1 FI 102372 B1 FI102372 B1 FI 102372B1 FI 923869 A FI923869 A FI 923869A FI 923869 A FI923869 A FI 923869A FI 102372 B1 FI102372 B1 FI 102372B1
Authority
FI
Finland
Prior art keywords
preparing
crystalline form
methyl
carbamyl derivative
physical
Prior art date
Application number
FI923869A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI102372B (fi
FI923869A0 (fi
FI923869L (fi
Inventor
Murray Watson Cuthbert
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of FI923869A0 publication Critical patent/FI923869A0/fi
Publication of FI923869L publication Critical patent/FI923869L/fi
Application granted granted Critical
Publication of FI102372B publication Critical patent/FI102372B/fi
Publication of FI102372B1 publication Critical patent/FI102372B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI923869A 1991-09-05 1992-08-28 Menetelmä karbamyylijohdannaisen kiteisen muodon valmistamiseksi FI102372B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9119001 1991-09-05
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (4)

Publication Number Publication Date
FI923869A0 FI923869A0 (fi) 1992-08-28
FI923869L FI923869L (fi) 1993-03-06
FI102372B FI102372B (fi) 1998-11-30
FI102372B1 true FI102372B1 (fi) 1998-11-30

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923869A FI102372B1 (fi) 1991-09-05 1992-08-28 Menetelmä karbamyylijohdannaisen kiteisen muodon valmistamiseksi

Country Status (21)

Country Link
US (2) US5352694A (enExample)
EP (1) EP0531078B1 (enExample)
JP (1) JP2914414B2 (enExample)
KR (1) KR100254710B1 (enExample)
AT (1) ATE138910T1 (enExample)
AU (1) AU646587B2 (enExample)
CA (1) CA2076722A1 (enExample)
CZ (1) CZ281999B6 (enExample)
DE (1) DE69211258T2 (enExample)
DK (1) DK0531078T3 (enExample)
FI (1) FI102372B1 (enExample)
GB (2) GB9119001D0 (enExample)
HK (1) HK18297A (enExample)
HU (2) HU213410B (enExample)
IL (1) IL102856A (enExample)
NO (1) NO178370C (enExample)
NZ (1) NZ244016A (enExample)
RU (1) RU2095348C1 (enExample)
SK (1) SK267092A3 (enExample)
TW (1) TW302359B (enExample)
ZA (1) ZA926374B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
CN101022796B (zh) 2004-07-14 2013-02-27 炎症研究中心有限公司 抑制肿瘤转移的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
NO923467L (no) 1993-03-08
EP0531078B1 (en) 1996-06-05
US5352694A (en) 1994-10-04
IL102856A0 (en) 1993-01-31
NO178370C (no) 1996-03-13
DE69211258T2 (de) 1996-10-02
DK0531078T3 (da) 1996-10-14
AU646587B2 (en) 1994-02-24
TW302359B (enExample) 1997-04-11
NO923467D0 (no) 1992-09-04
HU9202660D0 (en) 1992-10-28
FI102372B (fi) 1998-11-30
NZ244016A (en) 1995-01-27
ZA926374B (en) 1993-03-05
ATE138910T1 (de) 1996-06-15
GB9216774D0 (en) 1992-09-23
NO178370B (no) 1995-12-04
SK279657B6 (sk) 1999-02-11
JPH05194385A (ja) 1993-08-03
AU2101292A (en) 1993-03-11
RU2095348C1 (ru) 1997-11-10
EP0531078A1 (en) 1993-03-10
HU213410B (en) 1997-06-30
HK18297A (en) 1997-02-13
CZ281999B6 (cs) 1997-04-16
US5466826A (en) 1995-11-14
IL102856A (en) 1996-12-05
KR100254710B1 (ko) 2000-05-01
FI923869A0 (fi) 1992-08-28
HUT69696A (en) 1995-09-28
SK267092A3 (en) 1999-02-11
FI923869L (fi) 1993-03-06
CZ267092A3 (en) 1993-03-17
KR930005976A (ko) 1993-04-20
GB9119001D0 (en) 1991-10-23
JP2914414B2 (ja) 1999-06-28
DE69211258D1 (de) 1996-07-11
CA2076722A1 (en) 1993-03-06
HU210879A9 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
AU683442B2 (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
LU90846I2 (fr) Starlix-nateglinide et ses d-riv-s pharmaceutiquement acceptables
DZ1792A1 (fr) Une nouvelle forme de composé.
NZ242104A (en) Amides of aminoethylsubstituted benzothiazole, -thiazine, -oxazole and -oxazine derivatives; pharmaceutical compositions thereof
HU912002D0 (en) Process for the production of heterocyclene compounds
GR3020098T3 (en) 11-Beta-aryl-4-estrene, method for its production and its use as a medicine
NO933200D0 (no) Substituerte cykloheksanderivater, fremgangsm}te til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
FI923869A0 (fi) Farmaceutiska aemnen.
HU910748D0 (en) New substituted amine compounds and process for producing them
HUT55033A (en) Process for producing aminooligohydroxy derivatives and pharmaceutical compositions comprising same
JPS5620572A (en) 4-tert-butylbenzamide derivative and antimicrobial containing the same
EP0301401A3 (en) Leukotriene antagonists, process for their preparation, their use in the treatment of illnesses, as well as precursors

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ZENECA LIMITED

MA Patent expired